• Oscar Health Inc OSCR.N reported a quarterly adjusted loss of 62 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -66 cents. The mean expectation of eight analysts for the quarter was for a loss of 59 cents per share. Wall Street expected results to range from -68 cents to -48 cents per share.

• Revenue rose 67.1% to $2.39 billion from a year ago; analysts expected $2.47 billion.

• Oscar Health Inc's reported EPS for the quarter was a loss of 62 cents​.

• The company reported a quarterly loss of $153.55 million.

• Oscar Health Inc shares had risen by 24.6% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 3.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 2 "hold" and 2 "sell" or "strong sell."

• The average consensus recommendation for the life & health insurance peer group is also "hold"

Wall Street's median 12-month price target for Oscar Health Inc is $19.00

This summary was machine generated from LSEG data February 4 at 10:54 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)